This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

EEG Objectification in Neuropsychiatry

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2011 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Information provided by (Responsible Party):
Hadassah Medical Organization Identifier:
First received: August 22, 2011
Last updated: November 17, 2011
Last verified: August 2011
The main objective of the study is to evaluate the use of EEG in the management and follow-up of neuropsychiatric disorders. Secondary objectives are therefore better understanding of the pathological activations in neural network during neuropsychiatric disorders, their clinical evolution and response to therapies.

Condition Intervention
Personality Disorder Depression Neurodegeneration Alzheimer's Disease Epilepsy Device: EEG recording

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: EEG Objectification in Neuropsychiatry

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • percentage of fitting (0-100%) of EEG pattern to a previously identified electrophysiological "key" [ Time Frame: 1 year ]
    The study will decode an EEG-based "key" (or electrophysiological pattern) for specific effect (such as the use of anti-epileptic agent or a certain condition) by comparing EEG before and after the use of this agent. For each patient the statistical fitting of the recorded EEG to the key will be evaluated by percentage (0-100%), describing fitting of the individual patient's EEG to the identified key.

Estimated Enrollment: 100
Study Start Date: November 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: study group
EEG recording
Device: EEG recording
EEG recording

Detailed Description:
Patients are having EEG recordings as a routine part of their clinical evaluation and diagnosis. EEG recording is harmless, has no side effects, any radiation or any mechanical or electrical influence. It is of short duration and may be done in the EEG institute or the patient's room.

Ages Eligible for Study:   15 Years to 90 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • diagnosis of the investigated neuropsychiatric disease

Exclusion Criteria:

  • Other co-existing neuropsychiatric conditions
  • Refusal to participate in the study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01476228

Contact: shahar arzy, MD PhD

HMO Not yet recruiting
Jerusalem, Israel, 91120
Contact: Shahar Arzy, MD PhD    97226777741   
Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: shahar arzy, MD PhD HMO
  More Information

Responsible Party: Hadassah Medical Organization Identifier: NCT01476228     History of Changes
Other Study ID Numbers: 0394-11-HMO-CTIL
Study First Received: August 22, 2011
Last Updated: November 17, 2011

Additional relevant MeSH terms:
Alzheimer Disease
Personality Disorders
Nerve Degeneration
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders
Pathologic Processes processed this record on September 21, 2017